The United Laboratories International Holdings Limited
Pharmaceutical industry · Zhuhai, Guangdong
About The United Laboratories International Holdings Limited
The United Laboratories International Holdings, known as TUL, is a pharmaceutical group founded in 1990 and listed in Hong Kong (3933.HK), with its main production base in Zhuhai, Guangdong Province. Its official website puts the workforce at more than 18,000 employees and sales at over seventy countries and regions, with a marketing organisation of thousands of people in China.
The group is vertically integrated in antibiotics: it produces intermediates such as 6-APA, active ingredients for semi-synthetic penicillins and cephalosporins — with amoxicillin as its flagship product — and finished medicines in capsules, granules and injectables. Its bases are spread across Zhuhai, Zhongshan, Inner Mongolia and Hong Kong, including raw material, finished product and empty capsule plants, plus an animal healthcare line.
TUL works with hundreds of raw material and intermediate customers worldwide and runs around thirty formulation marketing offices. Its profile is that of one of China's major beta-lactam antibiotic producers, covering the full chain from intermediate to finished medicine.
The group is vertically integrated in antibiotics: it produces intermediates such as 6-APA, active ingredients for semi-synthetic penicillins and cephalosporins — with amoxicillin as its flagship product — and finished medicines in capsules, granules and injectables. Its bases are spread across Zhuhai, Zhongshan, Inner Mongolia and Hong Kong, including raw material, finished product and empty capsule plants, plus an animal healthcare line.
TUL works with hundreds of raw material and intermediate customers worldwide and runs around thirty formulation marketing offices. Its profile is that of one of China's major beta-lactam antibiotic producers, covering the full chain from intermediate to finished medicine.